Home › Funds › Boston Partners › DGX

Boston Partners position in DGX

QUEST DIAGNOSTICS INC · Health Care

Boston Partners reported holding 4,639,952 shares of DGX (QUEST DIAGNOSTICS INC) in its Q3 2026 13F filing — a position valued at US$1.08B, representing 0.97% of its reported portfolio and ranking #17 among its reported holdings. Boston Partners has disclosed DGX holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)4.64M sh
Reported value held$1.08B
Portfolio Weight0.97%
First reportedQ1 2025
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Boston Partners's DGX position evolved

Boston Partners first disclosed a stake in DGX in Q1 2025 at 2,295,746 shares (US$388.7M). The position peaked in Q3 2026 at 4,639,952 shares, worth US$1.08B. Across 7 filings, Boston Partners increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 4,639,952 shares valued at US$1.08B — a reduction of -104,521 shares quarter over quarter.. Notable position changes include a 32% increase in Q2 2025 (shares rose 6% over the following quarter), a 33% increase in Q3 2025 (shares fell 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 2.30M $388.72M New
Q2 2025 3.04M $545.32M Add
Q3 2025 4.04M $767.98M Add
Q4 2025 3.91M $680.02M Reduce
Q1 2026 4.01M $786.65M Add
Q2 2026 4.74M $1.00B Add
Q3 2026 4.64M $1.08B Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DGX and 13F data

DGX (QUEST DIAGNOSTICS INC) is a Health Care company. 25 other funds we track also report a position in DGX — the largest reported positions include EdgePoint Investment Group Inc. (US$476.4M), Grantham, Mayo, Van Otterloo & Co. LLC (US$449.9M), DAVIS SELECTED ADVISERS (US$309.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DGX

All DGX fund holders →

FAQ

How long has Boston Partners held DGX?

Boston Partners has disclosed DGX holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

What is Boston Partners's current position in DGX?

As of Q3 2026, Boston Partners holds 4.64M shares of DGX (QUEST DIAGNOSTICS INC), valued at $1.08B, representing 0.97% of its reported portfolio and ranking #17.

Has Boston Partners been buying or selling DGX?

In the latest 13F filing (Q3 2026), Boston Partners reduced its position in DGX. The position peaked in Q3 2026 at 4.64M shares.

Which other funds hold DGX?

Other major institutional holders of DGX include EdgePoint Investment Group Inc., Grantham, Mayo, Van Otterloo & Co. LLC, DAVIS SELECTED ADVISERS, among 25 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.